Biosysen Limited (HKG:1355)
Hong Kong · Delayed Price · Currency is HKD 0.1790
+0.0260 (16.99%)
Aug 4, 2026, 10:31 AM HKT
Biosysen Balance Sheet
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 2.44 | 13.86 | 2.21 | 2.43 | 14.3 |
Trading Asset Securities | - | - | - | 3.91 | 2.75 |
Cash & Short-Term Investments | 2.44 | 13.86 | 2.21 | 6.35 | 17.05 |
Cash Growth | -82.37% | 525.88% | -65.12% | -62.76% | -14.64% |
Accounts Receivable | 5.46 | 0.97 | 1.07 | 15.96 | 4.79 |
Other Receivables | 0.39 | 0.91 | 1.98 | 3.42 | 3.06 |
Receivables | 5.86 | 1.88 | 3.05 | 19.38 | 7.84 |
Inventory | 0.37 | 0.4 | 0.38 | 0.34 | 0.38 |
Prepaid Expenses | 1.02 | 0.57 | 0.33 | 0.71 | 1.16 |
Other Current Assets | 10.28 | 1.09 | 3.25 | 2.64 | 0.04 |
Total Current Assets | 19.97 | 17.8 | 9.22 | 29.43 | 26.47 |
Property, Plant & Equipment | 40.89 | 54.05 | 111.97 | 159.22 | 204.97 |
Goodwill | - | - | - | 1.96 | 2.06 |
Long-Term Deferred Tax Assets | - | - | 2.91 | 3.4 | 2.05 |
Other Long-Term Assets | 19.59 | 3.21 | 3.23 | 2.17 | 4.63 |
Total Assets | 80.44 | 75.05 | 127.32 | 196.17 | 240.18 |
Liabilities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 3.06 | 2.17 | 1.53 | 0.99 | 1.65 |
Accrued Expenses | 10.35 | 8.27 | 8.32 | 6.63 | 3.43 |
Short-Term Debt | 43.57 | 28.57 | 27.47 | 27.47 | 22.77 |
Current Portion of Leases | 22.45 | 29.77 | 25.95 | 22.57 | 25.03 |
Current Income Taxes Payable | 1.42 | 1.71 | 2.21 | 2.67 | 2.08 |
Current Unearned Revenue | - | 0.07 | 0.23 | 0.19 | 0.3 |
Other Current Liabilities | 5.81 | 2.71 | 15.71 | 30.24 | 30.6 |
Total Current Liabilities | 86.65 | 73.27 | 81.41 | 90.76 | 85.85 |
Long-Term Leases | 96.17 | 106.65 | 128.18 | 125.82 | 155.83 |
Other Long-Term Liabilities | 0.53 | 0.48 | 0.48 | 0.46 | 0.48 |
Total Liabilities | 183.34 | 180.4 | 210.06 | 217.04 | 242.16 |
Shareholders' Equity
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 11.93 | 5.38 | 4.48 | 4.48 | 4.48 |
Additional Paid-In Capital | 320.57 | 275.67 | 261.58 | 261.58 | 261.58 |
Retained Earnings | -374.95 | -331.42 | -310.3 | -272.12 | -264.33 |
Comprehensive Income & Other | 7.2 | 8.01 | 7.89 | 8.24 | 10.59 |
Total Common Equity | -35.25 | -42.36 | -36.35 | 2.18 | 12.32 |
Minority Interest | -67.65 | -63 | -46.39 | -23.05 | -14.3 |
Shareholders' Equity | -102.9 | -105.35 | -82.74 | -20.87 | -1.97 |
Total Liabilities & Equity | 80.44 | 75.05 | 127.32 | 196.17 | 240.18 |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 162.19 | 164.99 | 181.6 | 175.86 | 203.62 |
Net Cash (Debt) | -159.74 | -151.14 | -179.38 | -169.51 | -186.58 |
Net Cash Growth | - | - | - | - | - |
Net Cash Per Share | -0.17 | -0.27 | -0.40 | -0.38 | -0.42 |
Filing Date Shares Outstanding | 1,193 | 538.03 | 448.36 | 448.36 | 448.36 |
Total Common Shares Outstanding | 1,193 | 538.03 | 448.36 | 448.36 | 448.36 |
Working Capital | -66.68 | -55.47 | -72.19 | -61.34 | -59.38 |
Book Value Per Share | -0.03 | -0.08 | -0.08 | 0.00 | 0.03 |
Tangible Book Value | -35.25 | -42.36 | -36.35 | 0.22 | 10.26 |
Tangible Book Value Per Share | -0.03 | -0.08 | -0.08 | 0.00 | 0.02 |
Machinery | 32.37 | 19.89 | 20.53 | 20.69 | 21.64 |
Leasehold Improvements | 52.8 | 52.68 | 54.07 | 54.23 | 55.94 |